Clinical trial
Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of…
NCT00041483 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00041483 |
|---|---|
| Title | Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD |
| Official title | Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug, Other |
| Interventions | Anecortave Acetate 15 mg sterile suspension, Photodynamic Therapy (PDT) |
| Enrollment | 530 |
| Start date | Jun 1, 2002 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Aug 1, 2002 |
| Last update posted | Jul 1, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: